Dr Andrew Loblaw, BSc MSc MD FRCPC CIP FASCO, is a Radiation Oncologist,
Clinician Scientist, and dual Professor in
the Department of Radiation Oncology and
the Institute of Health Policy Management & Evaluation at the University of Toronto.
He received a Bachelor of Science in Physics from the University of British Columbia and his Doctor of Medicine from Queen’s University. He completed his specialty training in Radiation Oncology concurrent with a Masters degree in Clinical Epidemiology to graduate from Royal College’s Clinician Investigator Program all at the University of Toronto.
Dr Loblaw’s clinical practice and research interest focus on improving outcomes for men with prostate cancer and the healthcare system. He has a particularly interest in the design and conduct of clinical trials, the generation and dissemination of evidence-based guidelines and in image-guided radiotherapy.
Dr Loblaw is an Ontario Association of Radiation Oncology Clinician Scientist and a Scientist at the Sunnybrook Research Institute. A Fellow of the American Society of Clinical Oncology (FASCO 2018), he was previous Co-Chair of the ASCO’s Genitourinary Advisory Group and remains Co-Chair of the GU group for Cancer Care Ontario’s Program in Evidence-Based Care. He has authored over 225 peer-reviewed papers and has been awarded grant funding of over $37M.